- Platycodin D2
-
- $113.00
-
2026-08-30
- CAS:66663-90-9
- Purity: 99.92%
- Supply Ability: 10g
- Platycodin D2
-
- $8.00
-
2020-02-21
- CAS:66663-90-9
- Min. Order: 1g
- Purity: ＞98% HPLC
|
| | Platycodin D2 Basic information |
| Product Name: | Platycodin D2 | | Synonyms: | Platycodin D2;Olean-12-en-28-oic acid, 3-[(3-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy]-2,16,23,24-tetrahydroxy-, O-D-apio-β-D-furanosyl-(1→3)-O-β-D-xylopyranosyl-(1→4)-O-6-deoxy-α-L-mannopyranosyl-(1→2)-α-L-arabinopyranosyl ester, (2β,3β,16α)-;inhibit,Platycodin D2,Platycodin D 2,Inhibitor,Platycodin D-2;Platycodin D2, 10 mM in DMSO | | CAS: | 66663-90-9 | | MF: | C63H102O33 | | MW: | 1387.47 | | EINECS: | | | Product Categories: | | | Mol File: | 66663-90-9.mol |  |
| | Platycodin D2 Chemical Properties |
| density | 1.60±0.1 g/cm3 (20 ºC 760 Torr) | | solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | form | Powder | | pka | 12.70±0.70(Predicted) | | color | Off-white to light yellow | | InChIKey | PXQNZQURQNZGKZ-MXHOIBRBNA-N |
| | Platycodin D2 Usage And Synthesis |
| Description | Platycodin D2 , a less hemolytic saponin, can improve specific cellular and humoral responses to hepatitis B surface antigen in mice, it could be safely used as adjuvant eliciting Th1 and Th2 immune responses. Polygalacin D2 has anti-cancer activity, it exhibits significant inhibition on the proliferation of five kinds of cultured human tumor cell lines. | | Definition | ChEBI: Platycodin D2 is a triterpenoid saponin. It has a role as a metabolite. | | Biological Activity | Platycodin D2 is a saponin isolated from Platycodon grandiflorum, with anti-cancer activity. | | in vitro | A novel triterpenoid saponin, deapioplatycoside Ewas isolated from the root extract of Platycodon grandiflorum, together with the seven known saponins 2 - 8, i. e., platycoside E, deapioplatycodin D3 , platycodin D3, polygalacin D2, Platycodin D2 , deapioplatycodin D and platycodin D. The structure of the new saponin 1 was determined on the basis of spectral analysis and chemical evidence. | | target | IFN-γ | IL Receptor | HBV |
| | Platycodin D2 Preparation Products And Raw materials |
| Raw materials | Olean-12-en-28-oic acid, 3-[(3-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy]-2,16,23,24-tetrahydroxy-, O-D-apio-β-D-furanosyl-(1→3)-O-β-D-xylopyranosyl-(1→4)-O-3-O-acetyl-6-deoxy-α-L-mannopyranosyl-(1→2)-α-L-arabinopyranosyl ester, (2β,3β,16α)--->Olean-12-en-28-oic acid, 3-[(3-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy]-2,16,23,24-tetrahydroxy-, O-D-apio-β-D-furanosyl-(1→3)-O-β-D-xylopyranosyl-(1→4)-O-2-O-acetyl-6-deoxy-α-L-mannopyranosyl-(1→2)-β-L-arabinopyranosyl ester, (2β,3β,16α)- (9CI) |
|